Skip to main content

4 Result(s)

within P Falardeau Remove this filter

and

  1. No Access

    Article

    Modulation of the Contact Hypersensitivity Response by Æ-941 (Neovastat), a Novel Antiangiogenic Agent

    Background: Æ-941 (Neovastat) is an angiogenesis inhibitor noted to have antiinflammatory properties. Objective: We tested Neovastat in a contact hypersensitivity (CHS) model to determine...

    É. Dupont, B. Wang, A. J. Mamelak… in Journal of Cutaneous Medicine and Surgery:… (2003)

  2. No Access

    Article

    Dopamine D1 receptor protein is elevated in nucleus accumbens of human, chronic methamphetamine users

    Animal data have long suggested that an adaptive upregulation of nucleus accumbens dopamine D1 receptor function might underlie part of the dependency on drugs of abuse. We measured by quantitative immunoblott...

    J N Worsley, A Moszczynska, P Falardeau, K S Kalasinsky, G Schmunk… in Molecular Psychiatry (2000)

  3. No Access

    Chapter

    Effect of Chronic Levodopa, Bromocriptine and SKF-38393 on Dyskinesia and Dopamine Receptors in MPTP-parkinsonian Monkeys

    The existence of two brain dopamine (DA) receptor subtypes (D-1 and D-2) has now gained widespread acceptance. More recently, it has been reported that D-1 and D-2 receptors in normosensitive striatum are func...

    T. Di Paolo, P. Falardeau, P. Bédard in Pharmacology and Functional Regulation of … (1988)

  4. No Access

    Article

    Fatty acid composition of tissue phospholipids and prostaglandin excretion in hyperlipidemia induced in rats by implantation of the mammotropic pituitary tumor MtT-F4

    A mammotropic pituitary tumor, MtT-F4, was implanted into male Fisher 344 rats for a period of 4 weeks. This tumor induced growth retardation, hyperlipidemia, hepatic hypertrophy and adrenal hyperplasia. Lipids w...

    Y. S. Huang, A. Martineau, P. Falardeau, J. Davignon in Lipids (1983)